دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease: Insights From the AFIRE Trial
Koichi Kaikita, Satoshi Yasuda, Masaharu Akao, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa, on behalf of the AFIRE Investigators
doi : 10.1161/CIRCINTERVENTIONS.120.010476
Circulation: Cardiovascular Interventions. 2021;14
Early bleeding after percutaneous coronary intervention is associated with increased risk of death and myocardial infarction; however, the association between bleeding and subsequent major adverse cardiac and cerebrovascular events (MACCE) remains unclear in patients with atrial fibrillation and stable coronary artery disease. We thus aimed to investigate this association.
Association Between Stent Implantation and Progression of Nontarget Lesions in a Rabbit Model of Atherosclerosis
Jing Ma, Xiaoling Liu, Lei Qiao, Linlin Meng, Xingli Xu, Fei Xue, Cheng Cheng, Ziqi Han, Yue Lu, Wencheng Zhang, Peili Bu, Meng Zhang, Guipeng An, Huixia Lu, Mei Ni, Cheng Zhang, Yun Zhang
doi : 10.1161/CIRCINTERVENTIONS.121.010764
Circulation: Cardiovascular Interventions. 2021;14
Progression of nontarget lesions (NTLs) after percutaneous coronary intervention (PCI) has been reported. However, it remains unknown whether progression of NTLs was causally related to stenting. This study was undertaken to test the hypothesis that stent implantation triggers acute phase response and systemic inflammation which may be associated with progression of NTLs.
Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty Registry
Juliane Jurga, Karolina Elizabeth Szummer, Christian Lewinter, Linda Mellbin, Matthias Götberg, Sammy Zwackman, Johan Nilsson, Sebastian Völz, David Erlinge, Jonas Persson, Elmir Omerovic, Tomas Jernberg, Dimitrios Venetsanos
doi : 10.1161/CIRCINTERVENTIONS.121.010849
Circulation: Cardiovascular Interventions. 2021;14
In patients with chronic coronary syndrome undergoing percutaneous coronary intervention, the optimal timing of P2Y12 inhibitors’ administration is uncertain. We compared pretreatment versus treatment in the catheterization laboratory (In-Cathlab) in a real-world population.
Impact of Periprocedural Myocardial Injury and Infarction Definitions on Long-Term Mortality After Chronic Total Occlusion Percutaneous Coronary Intervention
Lei Song, Yang Wang, Changdong Guan, Tongqiang Zou, Zhongwei Sun, Lihua Xie, Rui Zhang, Kefei Dou, Weixian Yang, Yongjian Wu, Shubin Qiao, Bo Xu
doi : 10.1161/CIRCINTERVENTIONS.121.010923
Circulation: Cardiovascular Interventions. 2021;14
The prognostic implications of biomarker elevation following percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) lesions remain controversial. This study assessed the association of periprocedural myocardial injury and clinically relevant definition of periprocedural myocardial infarction with subsequent outcomes after CTO-PCI.
Measurement of Cardiac Biomarkers Following Percutaneous Coronary Interventions for Chronic Total Occlusions: Still a Work in Progress
Ion S. Jovin, Edward O. McFalls
doi : 10.1161/CIRCINTERVENTIONS.121.011390
Circulation: Cardiovascular Interventions. 2021;14
Compared Outcomes of ST-Segment–Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial
Pierre Denormandie, Tabassome Simon, Guillaume Cayla, Philippe Gabriel Steg, Gilles Montalescot, Isabelle Durand-Zaleski, Alicia le Bras, Hervé le Breton, Yann Valy, François Schiele, Thomas Cuisset, Gérald Vanzetto, Sébastien Levesque, Pascal Goube, Olivier Nallet, Denis Angoulvant, François Roubille, Anaïs Charles Nelson, Gilles Chatellier, Nicolas Danchin, … See all authors
doi : 10.1161/CIRCINTERVENTIONS.121.011314
Circulation: Cardiovascular Interventions. 2021;14
In patients with ST-segment–elevation myocardial infarction and multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions guided by fractional flow reserve (FFR) is superior to treatment of the culprit lesion alone. Whether deferring nonculprit PCI is safe in this specific context is questionable. We aimed to assess clinical outcomes at 1 year in ST-segment–elevation myocardial infarction patients with multivessel coronary artery disease and an FFR-guided strategy for nonculprit lesions, according to whether or not ?1 PCI was performed.
Differences Between Patients With Intermittent Claudication and Critical Limb Ischemia Undergoing Endovascular Intervention: Insights From the Excellence in Peripheral Artery Disease Registry
Kunal Patel, Yulun Liu, Farshid Etaee, Chirag Patel, Peter Monteleone, Mitul Patel, Mohamad Amer Alaiti, Christopher Metzger, Avantika Banerjee, Nicole Minniefield, Ishita Tejani, Emmanouil S. Brilakis, Mehdi H. Shishehbor, Subhash Banerjee
doi : 10.1161/CIRCINTERVENTIONS.121.010635
Circulation: Cardiovascular Interventions. 2021;14
There are limited data on differences in angiographic distribution of peripheral artery disease and endovascular revascularization strategies in patients presenting with intermittent claudication (IC) and critical limb ischemia (CLI). We aimed to compare anatomic features, treatment strategies, and clinical outcomes between patients with IC and CLI undergoing endovascular revascularization.
Endovascular Treatment of Symptomatic Peripheral Artery Disease: Where We Are and Where We Need to Go
Matthew C. Bunte
doi : 10.1161/CIRCINTERVENTIONS.121.011388
Circulation: Cardiovascular Interventions. 2021;14
Balloon-Augmented Leaflet Modification With Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction and Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction: Benchtop Validation and First In-Man Experience
Emily Perdoncin, Christopher G. Bruce, Vasilis C. Babaliaros, Dursun Korel Yildirim, Jeremiah P. Depta, James M. McCabe, Patrick T. Gleason, Joe Xie, Kendra J. Grubb, Gaetano Paone, Keshav Kohli, Norihiko Kamioka, Jaffar M. Khan, Toby Rogers, Robert J. Lederman, Adam B. Greenbaum
doi : 10.1161/CIRCINTERVENTIONS.121.011028
Circulation: Cardiovascular Interventions. 2021;14
Bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) and laceration of the anterior mitral leaflet to prevent outflow obstruction (LAMPOON) reduce the risk of coronary and left ventricular outflow obstruction obstruction during transcatheter aortic valve replacement and transcatheter mitral valve replacement. Despite successful laceration, BASILICA or LAMPOON may fail to prevent obstruction caused by inadequate leaflet splay in patients having challenging anatomy such as very small valve-to-coronary distance, diffusely calcified, rigid leaflets, or undergoing transcatheter aortic valve replacement inside existing transcatheter aortic valve replacement. We describe a novel technique of balloon-augmented (BA) leaflet laceration to enhance leaflet splay.
Midterm Outcomes Following Sutureless and Transcatheter Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
Victoria Vilalta, Alberto Alperi, Germán Cediel, Siamak Mohammadi, Eduard Fernández-Nofrerias, Dimitri Kalvrouziotis, Robert Delarochellière, Jean-Michel Paradis, Marta González-Lopera, Edgar Fadeuilhe, Xavier Carrillo, Omar Abdul-Jawad Altisent, Oriol Rodríguez-Leor, Pierre Voisine, Antoni Bayés-Genís, Josep Rodés-Cabau
doi : 10.1161/CIRCINTERVENTIONS.121.011120
Circulation: Cardiovascular Interventions. 2021;14
Sutureless-surgical aortic valve replacement (SU-SAVR) has been proposed as a surgical alternative for treating aortic stenosis, which facilitates a minimally invasive approach. While some studies have compared the early outcomes of SU-SAVR versus transcatheter aortic valve replacement (TAVR), most data were obtained in high-risk patients and/or limited to in-hospital outcomes. This study aimed to compare in-hospital and midterm clinical outcomes following SU-SAVR and TAVR in low-risk patients with aortic stenosis.
Sex-Based Differences in Outcomes With Percutaneous Transcatheter Repair of Mitral Regurgitation With the MitraClip System: Transcatheter Valve Therapy Registry From 2011 to 2017
Pedro A. Villablanca, Sreekanth Vemulapalli, Amanda Stebbins, Dadi Dai, Chak-yu So, Marvin H. Eng, Dee Dee Wang, Tiberio M. Frisoli, James C. Lee, Guson Kang, Molly Szerlip, Homam Ibrahim, Cezar Staniloae, Prakriti Gaba, Alejandro Lemor, Matthew Finn, Harish Ramakrishna, Mathew R. Williams, Martin B. Leon, William W. O’Neill, Binita Shah
doi : 10.1161/CIRCINTERVENTIONS.120.009374
Circulation: Cardiovascular Interventions. 2021;14
Women have a higher rate of adverse events after mitral valve surgery. We sought to evaluate whether outcomes after transcatheter edge-to-edge repair intervention by sex have similar trends to mitral valve surgery.
Long and Short of It: Understanding Transcatheter Edge-to-Edge Repair Outcomes for Mitral Regurgitation in Women
Saif Anwaruddin, Anita W. Asgar
doi : 10.1161/CIRCINTERVENTIONS.121.011389
Circulation: Cardiovascular Interventions. 2021;14
Gender Disparity Among Transcatheter Aortic Valve Replacement Operators in the United States
Timothy F. Simpson, Tamara M. Atkinson, Scott Chadderdon, Joaquin E. Cigarroa, Kendra J. Grubb, Gurion Lantz, Howard K. Song, Firas Zahr, Harsh Golwala
doi : 10.1161/CIRCINTERVENTIONS.121.010659
Circulation: Cardiovascular Interventions. 2021;14
Treatment and Outcomes of Device-Related Thrombus After Transcatheter Left Atrial Appendage Closure
David H. Yoo, Douglas N. Gibson, Jessica Funk, Kristi Pangborn, Gwen Janczyk, Matthew J. Price
doi : 10.1161/CIRCINTERVENTIONS.121.010889
Circulation: Cardiovascular Interventions. 2021;14
Kissing the Chimney: Managing a Protuberant Coronary Stent During Transcatheter Aortic Valve Replacement
Ayush Khurana, Daniel Obaid, Alexander Chase, David Smith
doi : 10.1161/CIRCINTERVENTIONS.121.011031
Circulation: Cardiovascular Interventions. 2021;14
Letter by Veen et al Regarding Article, “Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial”
Kevin M. Veen, Maximiliaan L. Notenboom, Johanna J.M. Takkenberg
doi : 10.1161/CIRCINTERVENTIONS.121.011377
Circulation: Cardiovascular Interventions. 2021;14
Response by Cremer and Jaber to Letter Regarding Article, “Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial”
Paul C. Cremer, Wael A. Jaber
doi : 10.1161/CIRCINTERVENTIONS.121.011430
Circulation: Cardiovascular Interventions. 2021;14
